| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Clinical Research Centers |
Division of Endocrinology (K.E.G., M.H.S., D.M.C., D.L.L.), Department of Radiology and Dotter Interventional Institute (G.M.N., S.L.B.), and Department of Neurosurgery (O.R.O., S.L.B.), Oregon Health Sciences University, Portland, Oregon 97201
Address all correspondence and requests for reprints to: Kathryn E. Graham, M.D., Division of Endocrinology L-607, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97201.
Inferior petrosal sinus sampling (IPSS) is used to distinguish pituitary Cushings disease from occult cases of the ectopic ACTH syndrome, but is limited in that it requires the use of ovine CRH (oCRH) and is not highly accurate at predicting the intrapituitary location of tumors. This study was designed to determine whether cavernous sinus sampling (CSS) is as safe and accurate as IPSS, whether CSS can eliminate the need for oCRH stimulation, and whether CSS can accurately predict the intrapituitary location of tumors.
Ninety-three consecutive patients with ACTH-dependent Cushings syndrome were prospectively studied with bilateral, simultaneous CSS before and after oCRH stimulation. Prediction of a pituitary or ectopic ACTH source was based on cavernous/peripheral plasma ACTH ratios. Intrapituitary tumor location was predicted based on lateralization (side to side) ACTH ratios. These predictions were compared to surgical outcome in the 70 patients who had surgically proven pituitary (n = 65) or ectopic (n = 5) disease.
CSS distinguished pituitary Cushings disease from the ectopic ACTH syndrome in 93% of patients with proven tumors before oCRH administration and in 100% of patients with proven tumors after oCRH. It was as safe and efficacious as published IPSS results. CSS accurately predicted the intrapituitary lateralization of the tumor in 83% of all patients and 89% of those patients with good catheter position and symmetric venous flow.
CSS is as safe and accurate as IPSS for distinguishing patients with pituitary Cushings disease from those with the ectopic ACTH syndrome. In addition, CSS appears to be superior to IPSS for predicting intrapituitary tumor lateralization.
This article has been cited by other articles:
![]() |
I. S. Kaskarelis, E. G. Tsatalou, S. V. Benakis, K. Malagari, I. Komninos, D. Vasiliadou, S. Tsagarakis, and N. Thalassinos Bilateral inferior petrosal sinuses sampling in the routine investigation of Cushing's syndrome: a comparison with MRI. Am. J. Roentgenol., August 1, 2006; 187(2): 562 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Swearingen, L. Katznelson, K. Miller, S. Grinspoon, A. Waltman, D. J. Dorer, A. Klibanski, and B. M. K. Biller Diagnostic Errors after Inferior Petrosal Sinus Sampling J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3752 - 3763. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lefournier, M. Martinie, A. Vasdev, P. Bessou, J.-G. Passagia, F. Labat-Moleur, N. Sturm, J.-L. Bosson, I. Bachelot, and O. Chabre Accuracy of Bilateral Inferior Petrosal or Cavernous Sinuses Sampling in Predicting the Lateralization of Cushing's Disease Pituitary Microadenoma: Influence of Catheter Position and Anatomy of Venous Drainage J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 196 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Deb and N. Natt 68-Year-Old Man With Generalized Weakness Mayo Clin. Proc., July 1, 2002; 77(7): 705 - 708. [PDF] |
||||
![]() |
F. S. Bonelli, J. Huston III, P. C. Carpenter, D. Erickson, W. F. Young Jr., and F. B. Meyer Adrenocorticotropic hormone-dependent Cushing's Syndrome: Sensitivity and Specificity of Inferior Petrosal Sinus Sampling AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 690 - 696. [Abstract] [Full Text] |
||||
![]() |
Pituitary Tumors in Children and Adolescents J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4317 - 4323. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |